Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality may take the sting out of Kids' IVs

NCT ID NCT07505225

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether watching an underwater video through virtual reality goggles or on a screen could help children aged 7-12 feel less pain, fear, and distress while getting an IV. Sixty-six children were split into three groups: VR goggles, video screen, or standard care. Researchers measured heart rate, oxygen levels, pain scores, and emotional reactions before, during, and after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality headset and on-screen video viewing
What this could lead to
If effective, this could provide a simple, non-drug way to ease pain and fear for children during needle procedures.
What could go wrong
This is a small, completed trial with only 66 children, so results may not apply to all kids or settings. The effect may be modest and not replace standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jan 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for the study * The child should be monitored at the hospital for a minimum of 30 minutes and a maximum of 6 hours during the planned training. * The child should be able to understand and speak Turkish fluently. * Child must be aged 7-12 years old. * Prior to the assessment process, the child's Wong-Baker Facial Expression Assessment Scale score must be 0. * There should be no condition in the hand and arm area that would prevent the establishment of planned peripheral venous access. Exclusion criteria from the study: * The child or parent does not wish to participate in the study * The child has a history of sedative or narcotic substance use within the last 24 hours * The child has received analgesia within the last 6 hours * The child has a visual health problem * The child has a hearing health problem * The child has a neurological disease that may be triggered by sight and sound * The child has a history of syncope during invasive procedures (blood sampling, intravenous access, etc) * The child has loss of sensation or tissue in the extremities (e.g., plaster casts) that would prevent intravenous access * The child has a wound/trauma to the scalp or any part of the head * The child has a health problem requiring isolation Exclusion criteria from the study group: * The child or parent expressing a desire to withdraw from the study at any stage of the research. * The child experiencing health problems during the procedure (syncope, seizures, etc.). * Initiating any medication or fluid treatment within 2 minutes of intravenous access (until the final test measurement).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Child are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Selçuk University

    Konya, Konya, 42208, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.